Target intelligence / Profile preview

Phosphatase and actin regulator 4 (PHACTR4)

Target
PHACTR4
Molecular classification
Protein phosphatase regulatory subunit, Actin-binding protein, Cytoskeletal regulator, Other
01

Overview

Phosphatase and actin regulator 4 (PHACTR4) is a member of the Phactr family of proteins, which bind both protein phosphatase 1 (PP1) and actin[1][4][5]. PHACTR4 regulates PP1 activity and cytoskeletal dynamics by interacting with actin and targeting PP1 towards specific substrates, thereby modulating cellular functions including neural tube closure, cell migration, and proliferation[1][5][6]. PHACTR4 acts as a tumor suppressor by restraining normal cell proliferation and transformation, in part through regulation of the Rb pathway and dephosphorylation of PP1 substrates; its loss through mutation or deletion is observed in multiple human cancers[6][7]. Beyond cancer, it is essential for neural development; mutations can cause neurodevelopmental defects such as neural tube and optic fissure closure anomalies[5][7]. PHACTR4 also binds intermediate filament proteins in neural cells and its activity is modulated by protein phosphorylation[3]. No drugs directly targeting PHACTR4 are currently known, and there are no established drug mechanisms, biomarkers, or specific safety liabilities documented beyond its essential developmental and tumor suppressor roles[5][6][7].

Other names
PPP1R124PRO2963FLJ13171Phactr4protein phosphatase 1 regulatory subunit 124PHAR4_HUMAN
02

Biological functions

Regulation of protein phosphatase 1 (PP1) activityActin binding and cytoskeletal organizationRegulation of cell proliferationTumor suppressionRegulation of cell migrationNeural development, including neural tube and optic fissure closure
03

Disease associations

Cancer (tumor suppressor function, deleted/mutated in multiple cancers)Hirschsprung disease 1Developmental defects (neural tube defects, coloboma, etc.)
04

Safety considerations

Developmental necessity: loss of PHACTR4 is embryonic lethal in mice with neural tube defectsTumor suppressor loss: deletion/mutation can contribute to cancer progression

Beyond the preview

Go deeper on Phosphatase and actin regulator 4 (PHACTR4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatase and actin regulator 4 (PHACTR4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call